Want to see DOC full AI Analyst Report?
DOC Stock Chart & Stats
$17.37
$0.33(1.66%)
At close: 4:00 PM EST
$17.37
$0.33(1.66%)
Day’s Range― - ―
52-Week Range$15.70 - $22.62
Previous CloseN/A
Volume1.14M
Average Volume (3M)6.50M
Market Cap
$15.90B
Enterprise Value$22.92B
Total Cash (Recent Filing)$1.17B
Total Debt (Recent Filing)$10.71B
Price to Earnings (P/E)71.4
Beta0.48
Next Earnings
Aug 04, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield5.42%
Share Statistics
EPS (TTM)0.32
Shares Outstanding689,419,700
10 Day Avg. Volume5,766,884
30 Day Avg. Volume6,500,969
Financial Highlights & Ratios
PEG Ratio-2.23
Price to Book (P/B)1.49
Price to Sales (P/S)3.97
P/FCF Ratio8.94
Enterprise Value/Market Cap1.44
Enterprise Value/Revenue7.98
Enterprise Value/Gross Profit421.07
Enterprise Value/Ebitda12.84
Forecast
1Y Price Target
$21.96Price Target Upside26.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)0.33
Revenue Forecast (FY)$2.97B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSustained operating and free cash flow (TTM FCFE > $1.1B) provides a durable internal funding base for dividends, buybacks, development and accretive acquisitions. Reliable cash generation supports REIT payout rules and cushions cyclical rent volatility over the medium term.
Outpatient Portfolio StabilityHigh occupancy, strong tenant retention and low leasing costs in outpatient medical create stable, contractually backed cash rents. This asset class is less cyclical than labs and provides predictable NOI that supports steady FFO and lowers portfolio cashflow volatility over multiple quarters.
Capital Recycling & Optionality (Janus, Buybacks, JV)The Janus IPO plus active recaps, JV transactions and a $100M buyback demonstrate disciplined capital allocation and listed‑asset optionality. Monetization flexibility lets management recycle capital into higher‑return acquisitions or debt reduction, enhancing long‑term FFO accretion potential.
Bears Say
Elevated LeverageMaterial leverage and higher net debt/EBITDA reduce financial flexibility and increase interest sensitivity. In a rising‑rate environment the balance sheet limits capacity for opportunistic buys, raises refinancing risk, and can force more dilutive or defensive capital actions, pressuring medium‑term FFO.
Life-science Vacancy & Leasing PressureSubstantial lab vacancy and notable near‑term expirations create ongoing rollover risk and downward rent pressure. Converting LOIs and re‑leasing vacant space at market or below underwriting will be necessary for durable earnings recovery and could weigh on FFO and margin sustainability for multiple quarters.
Refinancing & Interest Expense HeadwindsNear‑term maturities and guidance for higher interest expense raise refinancing risk and compress FFO. Increased debt service reduces free cash available for acquisitions or distributions and heightens earnings sensitivity to rate moves, limiting margin resilience over the medium term.
DOC FAQ
What was Healthpeak Properties, Inc.’s price range in the past 12 months?
Healthpeak Properties, Inc. lowest stock price was $15.70 and its highest was $22.62 in the past 12 months.
What is Healthpeak Properties, Inc.’s market cap?
Healthpeak Properties, Inc.’s market cap is $15.90B.
When is Healthpeak Properties, Inc.’s upcoming earnings report date?
Healthpeak Properties, Inc.’s upcoming earnings report date is Aug 04, 2026 which is in 15 days.
How were Healthpeak Properties, Inc.’s earnings last quarter?
Healthpeak Properties, Inc. released its earnings results on May 05, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.053 by $0.227.
Is Healthpeak Properties, Inc. overvalued?
According to Wall Street analysts Healthpeak Properties, Inc.’s price is currently Undervalued.
Does Healthpeak Properties, Inc. pay dividends?
Healthpeak Properties, Inc. pays a Monthly dividend of $0.102 which represents an annual dividend yield of 5.42%. See more information on Healthpeak Properties, Inc. dividends here
What is Healthpeak Properties, Inc.’s EPS estimate?
Healthpeak Properties, Inc.’s EPS estimate is 0.03.
How many shares outstanding does Healthpeak Properties, Inc. have?
Healthpeak Properties, Inc. has 689,419,700 shares outstanding.
What happened to Healthpeak Properties, Inc.’s price movement after its last earnings report?
Healthpeak Properties, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.053. Following the earnings report the stock price went up 18.113%.
Which hedge fund is a major shareholder of Healthpeak Properties, Inc.?
Currently, no hedge funds are holding shares in DOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthpeak Properties Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.96 (26.43% Upside)
$21.96 (26.43% Upside)
Blogger Sentiment
Bullish
DOC Sentiment 70%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Increased
By 221.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $213.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.30%
12-Months-Change
Fundamentals
Return on Equity
5.42%
Trailing 12-Months
Asset Growth
9.09%
Trailing 12-Months
Company Description
Healthpeak Properties, Inc.
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
DOC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
Overall the call conveyed constructive progress across multiple strategic fronts: outpatient medical fundamentals are strong (solid re-leasing spreads, high occupancy, low leasing costs), senior housing outperformance and the Janus Living IPO created clear value and near-term monetization optionality, and life science leasing momentum is building with targeted occupancy improvement guidance (+100 bps). Key near-term risks include lab rent pressure (quarterly re-leasing spreads softened), known vacates/expirations in life science that require conversion of pipeline, temporary earnings drag and public-company costs from the IPO, and refinancing/interest-rate headwinds. On balance, the company emphasized disciplined capital allocation (opportunistic acquisitions, recaps with Blackstone, share buybacks) and expects the recent transactions to be accretive over time.View all DOC earnings summariesDOC Revenue Breakdown
76.41% Rental and related revenues
21.40% Resident fees and services
2.19% Interest income and other

DOC Stock 12 Month Forecast
Average Price Target
$21.96
▲(26.43% Upside)
Technical Analysis
National Health Investors
―
Omega Healthcare
―
Sabra Healthcare REIT
―
―
Healthcare Realty Trust
―
Ownership Overview
0.24% Insiders
29.11% Mutual Funds
0.30% Other Institutional Investors
35.94% Public Companies and
Individual Investors









